Loading...
Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: Practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Sliwa-Hahnle, Karen Petrie, Mark C. Hilfiker-Kleiner, Denise Mebazaa, Alexandre Jackson, Alice Johnson, Mark R. van der Meer, Peter Mbakwem, Amam Bauersachs, J.
Sliwa-Hahnle, Karen
Petrie, Mark C.
Hilfiker-Kleiner, Denise
Mebazaa, Alexandre
Jackson, Alice
Johnson, Mark R.
van der Meer, Peter
Mbakwem, Amam
Bauersachs, J.
Abstract
Peripartum cardiomyopathy is an idiopathic cardiomyopathy presenting with heart failure secondary to left ventricular systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause for heart failure is identified. Outcome varies from full recovery to residual left ventricular systolic dysfunction and even death. Many women return to their physician to acquire information on their long‐term prognosis, to seek medical advice regarding contraception, or when planning a subsequent pregnancy. This position paper summarizes current evidence for long‐term outcome, risk stratification of further pregnancies and overall management. Based on the best available evidence, as well as the clinical experience of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy members, a consensus on pre‐ and postpartum management algorithms for women undergoing a subsequent pregnancy is presented.
Keywords
Peripartum cardiomyopathy, Subsequent pregnancy, Mortality
Date
2018
Type
Journal article
Journal
European Journal of Heart Failure
Book
Volume
20
Issue
6
Page Range
951-962
Article Number
ACU Department
Collections
Relation URI
Source URL
Event URL
Open Access Status
License
File Access
Controlled